International Hepatitis Symposium Heidelberg

Similar documents
International Hepatitis Symposium Heidelberg

Determinants of elimination and persistence of hepatitis viruses

LYON. FRANCE NOVEMBER / 2013 TRANSLATIONAL RESEARCH IN CHRONIC VIRAL HEPATITIS - BRIDGING BASIC SCIENCE AND CLINICAL RESEARCH

DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy. May 2-5, 2013 Villa La Collina Cadenabbia (Co), Italy

Dirk Heinz, Helmholtz Centre for Infection Research, Germany SESSION I: INDIVIDUALIZED MEDICINE TODAY AND TOMORROW

Molecular insights into the synergism between the HBV/HDV entry inhibitor Myrcludex B and Interferon

INDIVIDUALIZED INFECTION MEDICINE THE FUTURE IS NOW

Preliminary Program Application for CME credits submitted

Dirk Heinz, Helmholtz Centre for Infection Research, Germany SESSION I: INDIVIDUALIZED MEDICINE TODAY AND TOMORROW

Hinterzartener Kreis der DFG für Krebsforschung. From Molecular Mechanisms to Cancer Therapy

DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Targeted Cancer Therapy

Hepatitis B Virus infection: virology

DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy. May 15-18, 2014 Villa La Collina Cadenabbia (Co), Italy

CRC 992 Symposium on Medical Epigenetics 2018

CNIO- la Caixa Foundation Frontiers Meeting- 2nd-4th MAY 2017 MOLECULAR CHAPERONES IN CANCER

Fourth Symposium on Phospholipids in Pharmaceutical Research. 21 st 22 nd, September 2015 Heidelberg, Germany. 3rd Circular

HCV eradication with direct acting antivirals (DAAs)? Why is viral cure possible in HCV? Emilie Estrabaud

Bone Regeneration Summit 2018 Program March 23 24, 2018, Hamburg, GER

The Global Viral Hepatitis Summit 15 th International Symposium on Viral Hepatitis and Liver Disease Presentation O-09

This meeting has been made possible by an independent grant from Roche.


Adolfo Garcia-Sastre, New York, USA

SCIENTIFIC and SOCIAL PROGRAM

Global Strategies to Eliminate Hepatitis B (ICE-HBV) A/Prof Peter Revill Doherty Institute & ICE-HBV 3 December 2017

4th UpDate on Hepatology

Food, Microbiota and Immunity "For strong immunity - feed your microbiota well" June 7-10, 2017, Castle Třešť, Czech Republic

PROGRAM RNA VIRUS PERSISTENCE MEETING: MECHANISMS AND CONSEQUENCES. AUGUST 23-25, 2018 Institute of Virology, Medical Center - University of Freiburg

Foreword. I look forward to welcome you in Basel, our beautiful town in the centre of Europe

Antibodies & Complement Conference May 20-25, 2019

Bench & Bed Immunoloy 2015

Are Immune Modulators Really Needed to Cure HBV infection?

Future of Research Research of the Future. Programme

Christophe Mérieux Conference: New Trends in Tumor Virology

"Development and Clinical Progress. of DNA Vaccines" Program



Hepatitis C Virus resistance screening and phenotypic NS3-PI-Resistance characterization. Arevir Meeting, 08./09.05.

13th Residential Course on Clinical Pharmacology of Antiretrovirals. Turin, January 2018

ESMO Symposium on Immuno-Oncology Programme book

Entry inhibition. Stephan Urban, PhD

Practical experience in implementing surveillance of antiviral resistance in several European countries in accordance with personal data regulation

the 1st London Colloquium Status Epilepticus P R O G R A M M E The Institute of Child Health, Guilford Street, London WC1N

FEBS 2019 Advanced Lecture Course. Biological Surfaces and Interfaces: The Mechanistic View.

PROGRAM RNA The Nineteenth Annual Meeting of the RNA Society Quebec City, Canada June 03 08, 2014

VIRUSES AND BREAST CANCER

16 TH -17 TH INNOVATIONS IN ONCOLOGY NOVEMBER HEIDELBERG

23 ε Γηεκερίδα Ιογελώλ Ηπαηηηίδωλ Β θαη C «Ση. Χαηδεγηάλλες» 30 θαη 31 Ιαλοσαρίοσ 2016

EFORT Instructional Course

PRELIMINARY PROGRAM. 14:10-15:00 Session I: My Personal Experience CT/MR Chair: Herbert Frank Tulln, Austria Udo Hoffmann Boston, USA

Session 1 Clinical Manifestations of Cancer Cachexia (Chair: Aminah Jatoi, MD)

SCIENTIFIC and SOCIAL PROGRAM

The Temporal Lobes Language and beyond. 8 th Symposium on Behavioral Neurology Lucerne, 10 May Neurocenter. Kompetenz, die lächelt.

SECOND INTERNATIONAL MUNICH MEETING GERMAN HEART CENTER MUNICH

8 November Zurich

EULIS - PNL WORKSHOP 1-3 November 2018 Timisoara, Romania Programme

New Challenges. 20th International Symposium on Dental Hygiene 23rd to 25th June 2016 Basel Switzerland

Residual Cancer. May 3-5, International Symposium. on Minimal. Le Corum. > Preliminary. Program MONTPELLIER, FRANCE

SCIENTIFIC PROGRAM ORAL PRESENTATIONS. Friday October, 26 th OPENING SESSION

The International Coalition to Eliminate Hepatitis B.

HCC and the Hallmarks of Cancer: steps towards novel therapeutic strategies

18 th Annual Meeting Saturday, January 23, 2016 University of Lausanne

International Course in Contrast Enhanced Ultrasound

3 rd Muenster symposium on autoinflammatory syndromes in children and adolescents: Genetics, pathomechanisms, diagnostics and therapeutic targets

Hepatitis B. HBV Cure: Insights for the Biotechnology and the Research Analyst Community November 11, Lalo Flores, PhD Global Head HBV R&D

EUWAP. Berlin, November 22 23, European Workshop on Health and Disability Surveillance in Ageing Populations

International Society of Microbiota

Molecular Mechanisms of Intestinal Lipid Transport and Metabolism. July 6-11, 2014 Base Village Conference Center Snowmass, CO

Habilitation in Experimental Pathology, Medical Faculty, University Hospital

Microbiological Societies (IUMS) Congress This conference took place in Montreal, CANADA during

PRELIMINARY PROGRAMME

Exploring Human Host-Microbiome Interactions in Health and Disease 5-7 December 2018

Update on Biology and Clinical Impact of Occult Hepatitis B Virus Infection

This is a free sample of content from The Hepatitis B and Delta Viruses. Click here for more information on how to buy the book.

Masterclass on Clinical Research: How to design a clinical trial

HOWDOWEKNOW WHATWORKS?

Second China-U.S. Workshop on the Challenges of Emerging Infections, Laboratory Safety and Global Health Security

Virion Genome Genes and proteins Viruses and hosts Diseases Distinctive characteristics

Itinerary for the Field School. Social Science Research Techniques for Post Conflict Areas October 2015

Chairman: Ian LOFTUS www. aneurysm sealing london.com

KIDNEY LIVER MEETS FINAL PROGRAM KIDNEY MEETS LIVER. When the excellence in renal and liver medicine come together. XXXXXXX

European drugs summer school 2018

ESPACOMP SCIENTIFIC MEETING PROGRAM

AUSTRIAN SHOULDER SYMPOSIUM

HBV Novel Therapies Maria Buti MD, PhD

EPOS-EFORT Instructional Course. Paediatrics: Trauma Course. Workshops / Case discussions. Instructional Course

Is There a Best Direct Acting Antiviral Agent for HBV?

Infectious Diseases. Colin R. Howard ( 郝高林 ) Royal Veterinary College University of London ( 伦敦大学皇家兽医学院 )

NEURONAL CIRCUIT DYNAMICS ACROSS SCALES AND SPECIES

5 th International Workshop on Osteoarthritis Imaging

5th Bench and Bed Immunology Systemic Lupus (SLE) April, 19 th -20 th. Strasbourg PROGRAMME SPEAKERS / CHAIRS:

Hepatitis B (and D) Cure Strategies: How far are we?

June 4 th - 6 th 2014 Milazzo, Italy. 3 rd Workshop on Synaptic Plasticity: from bench to bedside

1 st Montreal Symposium on Immunogenetics of Infectious and Inflammatory diseases

Friday, May 18 SESSION Opening remarks L. Bolondi - Bologna (Italy)

Patella International IV

Atherosclerosis Mechanisms and novel therapeutic targets International Symposium

Hepatitis B Cure: from discovery to regulatory endpoints in HBV clinical research A summary of the AASLD/EASL statement

Transcription:

16 th May 18 th May 2018 International Hepatitis Symposium Heidelberg Ralf Bartenschlager s 60 th Birthday Symposium (16 th ) AND International Symposium of the TRR179 (17 th to 18 th ) Confirmed Speakers: Andrea Ablasser, Lausanne Andreas Bergthaler, Vienna Eva Billerbeck, New York Maura Dandri, Hamburg Carlo Ferrari, Parma Markus Heim, Basel Matteo Iannacone, Milan Stanley M. Lemon, Chapel Hill Wenhui Li, Peking Mala Maini, London Darius Moradpour, Lausanne Christine Neuveut, Paris Thomas Pietschmann, Hannover Barbara Rehermann, Bethesda Charles M. Rice, New York Naglaa Shoukry, Montreal John E. Wherry, Philadelphia Adam Zlotnick, Bloomington Please register at http://www.trr179.de/en/news/symposium until 15 th April 18

International Hepatitis Symposium Ralf Bartenschlager s 60th Birthday Symposium Symposium Chair: PD Dr. Volker Lohmann Department of Infectious Diseases, Molecular Virology, Heidelberg University Hospital; International Symposium of the TRR179 Symposium Chairs: Prof. Dr. Ralf Bartenschlager Department of Infectious Diseases, Molecular Virology, Heidelberg University Hospital; Research Division Virus-associated Carcinogenesis, German Cancer Research Center Heidelberg; German Centre for Infection Research (DZIF e.v.) Prof. Dr. Robert Thimme Department of Internal Medicine II, University Hospital Freiburg Prof. Dr. Ulrike Protzer Institute of Virology, TU München/ Helmholtz Zentrum München; German Centre for Infection Research (DZIF e.v.) Organizing Committee: PD Dr. Volker Lohmann Dr. Sandra Bühler Dr. Catherine Moreau Steffi Schimang Organizing Committee: Prof. Dr. Ralf Bartenschlager Prof. Dr. Robert Thimme Prof. Dr. Ulrike Protzer Dr. Sandra Bühler Dr. Catherine Moreau Steffi Schimang Conference Language: The conference language will be English. Registration: Admission free! Please register until 15 th April 2018 http://www.trr179.de/en/news/symposium/ Contact: Dr. Sandra Bühler or Steffi Schimang, Department of Infectious Diseases, Molecular Virology, Im Neuenheimer Feld 344, 69120 Heidelberg Tel.: +49 6221 56 7895 or 7598 2

Ralf Bartenschlager s 60 th Birthday AGENDA Ralf Bartenschlager s 60 th Birthday Symposium Wednesday, 16 th May 2018 10:00 Welcome addresses 11:00 Darius Moradpour, Lausanne, Switzerland 11:45 13:00 LUNCH 13:00 Michael Nassal, Freiburg, Germany 13:20 Ursula Klingmüller, Heidelberg, Germany 13:40 tba 14:00 Rene Devos, St. Albans, United Kingdom 14:20 Matthias Reddehase, Mainz, Germany 14:40 Thomas Pietschmann, Hannover, Germany 15:00 David Paul, Cambridge, United Kingdom 15:30 16:00 COFFEE BREAK 16:00 Laurent Chatel-Chaix, Montreal, Canada 16:20 Marco Binder, Heidelberg, Germany 16:40 Stefan Seitz, Heidelberg, Germany 17:00 Mathias Heikenwälder, München and Heidelberg, Germany 17:20 Stephan Urban, Heidelberg, Germany 17:40 Charles Rice, New York, USA 18:15-20:30 TRR179 Welcome Reception 3

International Symposium of the TRR179 Thursday, 17 th May 2018 AGENDA International Symposium of the TRR179 09:00 Welcome address Ralf Bartenschlager Inflammation and Microbiome Chairman: Hartmut Hengel 09:20 Role of microbiota in host fitness Barbara Rehermann, Bethesda, USA 09:45 Hepatic metabolism directs antiviral immunity in persistent infection Andreas Bergthaler, Vienna, Austria 10:10 Lymphotoxin β receptor signalling-dependent control of virus clearance in chronic hepatitis B virus and hepatitis C virus infections Mathias Heikenwälder TRR179 10:25 10:50 COFFEE BREAK Innate Immune Response Chairman: Andreas Pichlmair 10:50 Intracellular DNA sensing strategies Andrea Ablasser, Lausanne, Switzerland 11:15 Dissecting NK cell-mediated immune responses against hepatitis B virus and hepatitis C virus infection Adelheid Cerwenka TRR179 11:30 Mechanisms of interferon induction by hepatitis D virus and impact of chronic innate immune activation on antiviral immunity Veit Hornung/Percy Knolle TRR179 11:45 Strategies to harness an effective antiviral response targeting hepatitis B virus Ursula Klingmüller/Jens Timmer TRR179 4

International Symposium of the TRR179 12:00 Global effects on host cell signalling by continuous stimulation of innate antiviral responses in persistent viral infections Marco Binder/Andreas Pichlmair TRR179 12:15 Role of innate immune response in HCV infection Markus Heim, Basel, Switzerland 12:45 13:45 LUNCH In Vivo Imaging and Mouse Models Chairman: Percy Knolle 13:45 Pathogenetic mechanisms underlying liver immunopathology during viral hepatitis Matteo Iannacone, Milan, Italy 14:10 Molecular mechanisms of HBV and HDV persistence Maura Dandri, Hamburg, Germany 14:35 Dynamics of antiviral T cell immunity against viral infection of the liver Dirk Wohlleber/Vasilis Ntziachristos TRR179 14:50 Mouse models of acute and chronis hepacivirus infection Eva Billerbeck, New York, USA Cell biology of hepatitis virus replication Chairman: Dirk Grimm 15:15 Unravelling the role of DNA repair in the formation of the hepatitis B virus cccdna persistence reservoir Sabrina Schreiner/Michael Nassal TRR179 15:30 Contribution of innate immune response to persistence versus clearance of hepatitis C virus and hepatitis A virus infections Volker Lohmann TRR179 15:45 tba Alessia Ruggieri TRR179 16:00 Means of modification and degradation of hepatitis B virus cccdna Ulrike Protzer/ Dirk Grimm TRR179 5

International Symposium of the TRR179 16:15 16:45 COFFEE BREAK Chairman: Michael Nassal 16:45 Highjacking of cell regulation by HBV : a 3D nuclear perspective Christine Neuveut, Paris, France 17:10 Assembly and Misassembly of HBV capsids Adam Zlotnick, Bloomington, USA 17:35 Determinants of success and failure to control hepatitis C virus infection by the interferon system Ralf Bartenschlager TRR179 17:50 Hepatitis B virus X-protein-mediated transcriptional regulation and stability of cccdna Stephan Urban TRR179 18:05 HBV entry Wenhui Li, Peking, China 18:30 Cellular egress and entry of quasi-enveloped hepatitis A virus Stanley M. Lemon, Chapel Hill, USA 19:00 SPEAKERS DINNER Castle Schriesheim Bus transfer Friday, 18 th May 2018 Adaptive Immune Response Chairman: Robert Thimme 09:15 T cell exhaustion in chronic HBV infection or T cell exhaustion in chronic HBV infection and potential correction strategies Carlo Ferrari, Parma 09:40 Protective immunity against HCV, insights from reinfection studies Naglaa Shoukry, Montreal, Canada; Cooperation CanHepc 6

International Symposium of the TRR179 10:05 Characterization of follicular T helper cell responses in viral hepatitis Tobias Böttler TRR179 10:20 Heterogeneity of HBV- and HCV-specific CD8+ T cells in chronic infection Maike Hofmann/Robert Thimme TRR179 10:35 Role of myeloid cells in the liver for antiviral immunity Percy Knolle TRR179 10:50 Viral escape from dominant virus-specific CD8+ T cell responses in hepatitis B virus (HBV) mono-infection and HBV/hepatitis D virus co-infection and strategies to restore antiviral CD8+ T cell response Christoph Neumann-Häfelin TRR179 10:50 11:20 COFFEE BREAK 11:20 Immune correlates of viral persistence and liver damage Mala Maini, London 11:45 T-cell exhaustion John E. Wherry, Philadelphia 12:10 Farewell Ralf Bartenschlager, Robert Thimme and Ulrike Protzer 12:15 LUNCH FOR TAKE AWAY 7

8